Research Solutions (RSSS) Q1 2025 earnings summary

Executive summary

• Total revenue grew 20% year-over-year to $12 million, driven by platform expansion and the Scite acquisition, with ARR up 60% to $17.6 million.

• Net income reached $669,000, reversing a net loss of $988,000 in the prior year, and adjusted EBITDA was $1.3 million, up from a loss of $441,000.

• Gross profit increased 43% to $5.8 million, with gross margin improving to a record 47.9% from 40.1% year-over-year.

• Cash and equivalents rose to $6.9 million, with $843,000 in positive operating cash flow for the quarter.

• Deployments and incremental ARR were lower due to seasonality and longer sales cycles, but B2C subscriptions rebounded in Q2.

Financial highlights

• Platform revenue surged 67% to $4.3 million, now 36% of total revenue, while transaction revenue grew 3.4% to $7.7 million.

• Gross margin reached 47.9%, platform margin was 87.4%, and transaction margin was 25.7%.

• Operating expenses were flat at $5.1 million year-over-year.

• Diluted EPS was $0.02, compared to a loss of $0.04 per share in the prior year quarter.

• No customers accounted for more than 10% of revenue or accounts receivable.

Outlook and guidance

• Management expects continued growth from expanded platform deployments, integration of acquisitions, and ongoing product enhancements.

• Q2 adjusted EBITDA is expected up year-over-year but down sequentially due to seasonality and increased SG&A.

• Q3 and Q4 are anticipated to be the strongest quarters for transactions, profitability, and cash flow.

• Inflation and interest rate pressures are noted as potential future risks.